We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Pfizer Halts Ranbaxy's Diflucan Generic With Court Ruling

Law360 (March 12, 2004, 12:00 AM EST) -- The U.S. District Court in Washington, D.C. has upheld Pfizer’s six-month pediatric exclusivity for its top selling anti-fungal medicine, Diflucan.

The court’s decision keeps a generic version by Indian drugmaker Ranbaxy Laboratories Ltd. off the market until July 29.

The ruling came in response to a suit filed by the generic manufacturer Ranbaxy contending that its generic version of Diflucan was not subject to the exclusivity period for Pfizer's product.

A previous lawsuit brought by Pfizer against Ranbaxy for infringement of its patent for Diflucan was...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.